Related Experiment Video
Updated: Dec 17, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights
Razieh Kebriaei1, Seth A Rice1, Nivedita B Singh1
1Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, USA.
Background:
Increasing application of vancomycin due to the high prevalence of MRSA infections has led to the emergence of vancomycin intermediate-resistant Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA). Consequently, the need for alternative therapies that target MRSA has become evident.
Objectives:
To evaluate the synergy between (lipo)glycopeptides (LGP/GPs) (vancomycin, teicoplanin, telavancin, dalbavancin and oritavancin) and β-lactams (ceftaroline, cefepime, cefazolin and oxacillin) against MRSA, hVISA, VISA and daptomycin non-susceptible (DNS) phenotypes.
Methods:
Twenty randomly selected clinical MRSA strains (i.e. 5 MRSA, 5 hVISA, 5 VISA and 5 DNS) were assessed versus LGP/GPs alone and LGP/GPs in combination with β-lactams for MICs. Although verification of antibiotic potency against bacterial strains is assessed by the microbroth dilution (MBD) MIC method recommended by the CLSI, some antibiotics need modified assay conditions in order to demonstrate their optimal activity.
Results:
Addition of β-lactams reduced MIC values of LGP/GPs against all strains (up to 160-fold reduction). In general, LGPs (dalbavancin, oritavancin and telavancin) were more active (significant differences in MIC values, up to 8-fold) compared with vancomycin and teicoplanin. The majority of these combinations were bactericidal and superior to any single agent.
Conclusions:
This report has examined the susceptibility patterns of LGP/GPs and their combination with β-lactams. Of interest, the impact of susceptibility tests (in terms of MIC plates and their surface area) on the synergistic activity in 24 h time-kill experiments was apparent for LGPs. Further clinical research is required to investigate synergy with LGP/GPs and β-lactams against these Staphylococcus strains.
Insights
Combining lipoglycopeptides (LGPs) with beta-lactams shows significant synergy against resistant Staphylococcus aureus strains, including VISA and hVISA. These combinations offer a promising alternative therapy for challenging MRSA infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Rising prevalence of Methicillin-Resistant Staphylococcus aureus (MRSA) infections necessitates alternative therapies.
- Emergence of vancomycin intermediate-resistant Staphylococcus aureus (VISA) and heterogeneous VISA (hVISA) strains limits treatment options.
Purpose of the Study:
- To evaluate the synergistic efficacy of (lipo)glycopeptides (LGPs) combined with beta-lactams against various resistant Staphylococcus aureus phenotypes.
- To assess the activity of specific LGP/beta-lactam combinations against MRSA, hVISA, VISA, and daptomycin non-susceptible (DNS) strains.
Main Methods:
- Microbroth dilution (MBD) method was used to determine Minimum Inhibitory Concentrations (MICs).
- Twenty clinical MRSA strains (5 each of MRSA, hVISA, VISA, DNS) were tested against individual agents and combinations.
- Modified assay conditions were considered for optimal antibiotic activity assessment.
Main Results:
- Addition of beta-lactams significantly reduced LGP MIC values, with reductions up to 160-fold.
- Lipoglycopeptides (dalbavancin, oritavancin, telavancin) demonstrated superior activity compared to vancomycin and teicoplanin.
- Most LGP/beta-lactam combinations exhibited bactericidal activity, outperforming single agents.
Conclusions:
- LGP and beta-lactam combinations show significant synergistic activity against resistant Staphylococcus aureus.
- The study highlights the potential of these combinations as effective therapeutic strategies.
- Further clinical research is warranted to confirm the in vitro findings in patient populations.
More Related Videos
11:15Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Bacterial Cell Wall
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Gene Regulation in Microbial Communities: Quorum Sensing